Results 121 to 130 of about 94,588 (272)

Bevacizumab Pretreatment in Vitrectomy with Silicone Oil for Severe Diabetic Retinopathy

open access: yes, 2011
Purpose: To evaluate the effects of intravitreal bevacizumab pretreatment in vitrectomy with silicone oil infusion for severe diabetic retinopathy. Methods: Forty-one eyes (39 patients) that underwent primary vitrectomy with silicone oil tamponade for ...
葉伯廷;楊中美;林友祺;陳慕師;楊長豪   +1 more
core   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Delayed recurrent hyphema following trabeculectomy: A case series of swan syndrome managed with anti-VEGF therapy

open access: yesIndian Journal of Ophthalmology. Case Reports
Swan syndrome refers to delayed recurrent intraocular bleeding caused by vascular ingrowth at the site of a prior surgical wound. Although classically described after cataract surgery, it has rarely been reported following trabeculectomy. We report three
Priyanka Sudhakar   +2 more
doaj   +1 more source

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion

open access: yes, 2018
Meng-Ju Tsai,1 Yi-Ting Hsieh,1,2 Yi-Jie Peng1 1Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan; 2Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan Aim: To ...
Hsieh YT, Tsai MJ, Peng YJ
core  

The effect of intravitreal bevacizumab and ranibizumab on cutaneous tensile strength during wound healing

open access: yes, 2013
John B Christoforidis,1 Jillian Wang,2 Angela Jiang,2 James Willard,5 Cedric Pratt,2 Mahmoud Abdel-Rasoul,3 Sashwati Roy,4 Heather Powell51Department of Ophthalmology and Vision Science, College of Medicine, The University of Arizona, Tucson, AZ, USA ...
Christoforidis JB   +7 more
core  

Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia

open access: yes, 2017
Objectives: To evaluate the effectiveness of intravitreal bevacizumab (IVB) in patients with subretinal neovascularization secondary to type 2 juxtafoveal telangiectasia. Materials and Methods: Ten eyes of 10 patients were included in this retrospective
Abdullah Özkaya   +6 more
core   +1 more source

Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy

open access: yes, 2009
Ashraf M El-BatarnyAssistant Professor of Ophthalmology, Tanta University, Egypt; Chief of Vitreoretinal Service, Magrabi Eye and Ear Hospital, Muscat, Sultanate of OmanPurpose: To evaluate the effect of intravitreal injection of Avastin, bevacizumab ...
Ashraf M El-Batarny
core  

Aflibercept monotherapy or bevacizumab first for diabetic macular edema

open access: yesIndian Journal of Ophthalmology
Purpose: Clinical outcome and switch patterns with bevacizumab first treatment strategy for patients with newly diagnosed neovascular age-related macular degeneration (nAMD).
Avner Hostovsky   +2 more
doaj   +1 more source

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates

open access: yes, 2014
Sohee Jeon, Won Ki LeeDepartment of Ophthalmology, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaBackground: We evaluated the efficacy of intravitreal bevacizumab on diabetic macular edema with ...
Jeon S, Lee WK
core  

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions

open access: yes, 2017
Biljana Ivanovska Adjievska,1 Salih Boskurt,1 Nikola Orovcanec,2 Vesna Dimovska-Jordanova3 1Department for Posterior Segment, European Eye Hospital, Skopje, Republic of Macedonia; 2Department for Medical Statistics, Institute for Epidemiology and ...
Ivanovska Adjievska B   +3 more
core  

Home - About - Disclaimer - Privacy